» Articles » PMID: 19180204

Efficacy of Amodiaquine/artesunate Combination Therapy for Uncomplicated Malaria in Children Under Five Years in Ghana

Overview
Journal Ghana Med J
Specialty General Medicine
Date 2009 Jan 31
PMID 19180204
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In 2005, following several years of declining efficacy of chloroquine, the Ministry of Health recommended the use of Amodiaquine/Artesunate combination therapy for the treatment of uncomplicated malaria. A system of continuous monitoring of therapeutic responses has been established in 10 district hospitals across the country. The data gathered will enable National Malaria Control Programme (NMCP) to respond to changes in the efficacy of the new treatment in a timely manner.

Objectives: To determine the 28 day therapeutic efficacy of Amodiaquine/Artesunate (AQ/AS) combination treatment in children with uncomplicated malaria in Ghana.

Methods: Children aged 6 - 59 months attending clinic with signs/symptoms of uncomplicated malaria at 9 district hospitals (3 in each of the 3 eco-epidemiological zones of the country) were eligible for enrolment. Enrolled children were followed up after treatment for a total of 28 days to record the clinical and parasitological resolution of their malaria episode as well as any adverse drug reactions.

Results: Treatment resulted in rapid and complete cure in almost all the children; 99.3% 14 days after treatment and 93.0%, 28 days after treatment. The majority of treatment failures on D28 were seen in the 3 sites located in the forest zones (Sunyani, Bekwai and Begoro). There was no case of Early Treatment Failure at both D14 and D28 assessments. Adverse events (AE's) were minimal, less than 4%, with the most common complaint being vomiting.

Conclusion: AQ/AS combination for uncomplicated malaria is efficacious and safe in children less than 5 years.

Citing Articles

Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana.

Abuaku B, Boateng P, Peprah N, Asamoah A, Duah-Quashie N, Matrevi S Front Cell Infect Microbiol. 2023; 12:1058660.

PMID: 36683700 PMC: 9853013. DOI: 10.3389/fcimb.2022.1058660.


Trends and predictive factors for treatment failure following artemisinin-based combination therapy among children with uncomplicated malaria in Ghana: 2005-2018.

Abuaku B, Duah-Quashie N, Quashie N, Gyasi A, Afriyie P, Owusu-Antwi F BMC Infect Dis. 2021; 21(1):1255.

PMID: 34911501 PMC: 8672499. DOI: 10.1186/s12879-021-06961-4.


Ex vivo Sensitivity Profile of Clinical Isolates to a Panel of Antimalarial Drugs in Ghana 13 Years After National Policy Change.

Ofori M, Kploanyi E, Mensah B, Dickson E, Kyei-Baafour E, Gyabaa S Infect Drug Resist. 2021; 14:267-276.

PMID: 33536768 PMC: 7850388. DOI: 10.2147/IDR.S295277.


Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria.

Anyorigiya T, Castel S, Mauff K, Atuguba F, Ogutu B, Oduro A Malar J. 2021; 20(1):18.

PMID: 33407454 PMC: 7788723. DOI: 10.1186/s12936-020-03553-6.


Efficacy of Artemether-Lumefantrine on various and genes isolated in Ghana.

Aninagyei E, Tetteh C, Oppong M, Boye A, Acheampong D Parasite Epidemiol Control. 2020; 11:e00190.

PMID: 33163636 PMC: 7607505. DOI: 10.1016/j.parepi.2020.e00190.


References
1.
Barennes H, Nagot N, Valea I, Koussoube-Balima T, Ouedraogo A, Sanou T . A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso. Trop Med Int Health. 2004; 9(4):438-44. DOI: 10.1111/j.1365-3156.2004.01224.x. View

2.
Trape J, Pison G, Preziosi M, Enel C, Desgrees du Lou A, Delaunay V . Impact of chloroquine resistance on malaria mortality. C R Acad Sci III. 1998; 321(8):689-97. DOI: 10.1016/s0764-4469(98)80009-7. View

3.
Landgraf B, Kollaritsch H, WIEDERMANN G, Wernsdorfer W . Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren. Trans R Soc Trop Med Hyg. 1994; 88(4):440-2. DOI: 10.1016/0035-9203(94)90424-3. View

4.
Helleberg M, Goka B, Akanmori B, Obeng-Adjei G, Rodriques O, Kurtzhals J . Bone marrow suppression and severe anaemia associated with persistent Plasmodium falciparum infection in African children with microscopically undetectable parasitaemia. Malar J. 2005; 4:56. PMC: 1315355. DOI: 10.1186/1475-2875-4-56. View

5.
Driessen G, van Kerkhoven S, Schouwenberg B, Bonsu G, Verhave J . Sulphadoxine/pyrimethamine: an appropriate first-line alternative for the treatment of uncomplicated falciparum malaria in Ghanaian children under 5 years of age. Trop Med Int Health. 2002; 7(7):577-83. DOI: 10.1046/j.1365-3156.2002.00910.x. View